Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja CSIS WARRANT SERIES I (CSIS-W) vs Champion Pacific Indonesia Tbk. (IGAR)

CSIS WARRANT SERIES ITrading
Champion Pacific Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan CSIS WARRANT SERIES I dan Champion Pacific Indonesia Tbk.: CSIS WARRANT SERIES I diperdagangkan di Rp88 (kapitalisasi pasar 4,34 M, volume 24 jam 16,1 rb), sedangkan Champion Pacific Indonesia Tbk. diperdagangkan di Rp414 (kapitalisasi pasar 384,1 M, volume 24 jam 16,2 rb). Perbedaan utamanya: Champion Pacific Indonesia Tbk. jauh lebih besar — sekitar 88,5× kapitalisasi pasar CSIS WARRANT SERIES I, dan Champion Pacific Indonesia Tbk. lebih aktif diperdagangkan (16,2 rb vs 16,1 rb). Mana yang lebih baik tergantung tujuan investasimu.

CSIS-WIGAR
Kapitalisasi Pasar
4,34 M384,1 M
Volume
16,1 rb16,2 rb
Lot
161162
Perputaran
1,31 jt6,65 jt
Harga Rata-rata
81,55410,64
Nilai Transaksi
1,31 jt6,65 jt
Harga Ekuilibrium Indikatif
88414
Volume Ekuilibrium Indikatif
11

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

IGAR
Lihat detail

Tentang CSIS WARRANT SERIES I

PT Cahayasakti Investindo Sukses Tbk (the Company) was established based on the Deed of Notary Djurnawati Soetarmono, SH, No. 52 dated June 2, 1995. The Company belongs to a group of companies owned by PT Andalan Utama Bintara.

Selengkapnya di halaman CSIS-W

Tentang Champion Pacific Indonesia Tbk.

PT Champion Pacific Indonesia Tbk (The Company) formerly PT Kageo Igar Jaya was established under the name of PT Igar Jaya based on Notarial deed No. 195 dated October 30, 1975, of Mohamad Said Tadjoedin, SH, Notary in Jakarta. Igar Jaya was founded in October 1975 in the Republic of Indonesia as a joint venture with Owens-Illinois, a leading glass container manufacturer in the United States, initially in the production of glass vial and ampoules to support Indonesia’s pharmaceutical industry. However since 1987, due to customer demand, the Company has expanded to the business of plastic, aluminum foil (flexible packaging) and paper folding carton packaging products as well as disposable syringe not only to meet the needs of Indonesia’s pharmaceutical industry but also its cosmetic and food industries. In 1988, the Company relinquished its joint venture status with a view to entering the global market and today has customers in 14 countries outside Indonesia. These include: Britain, Bangladesh, Canada, Guinea, Malaysia, Mauritius, Pakistan, the Philippines, Saudi Arabia, Singapore, Thailand, Trinidad & Tobago, the United States and Zaire.

Selengkapnya di halaman IGAR